Delivery Order SPE2DB24D2100-SPE2DB25FBFJP
- Not listed
- The Defense Logistics Agency awarded a $20,902.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This contract, which carries an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $6,208.02. This firm fixed-price delivery order is a non-set-aside award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,151.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a $7,024.71 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 and running through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens valued at $4,370.58 on July 29, 2025, with ultimate completion scheduled for July 30, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $3,647.57. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $70,021.66 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency (DLA) awarded a $16,914.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens valued at $3,050.32 with a completion date of August 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $93,571.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and extending through December 2026. The...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFJPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $67,987.81 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 22, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for completion by July 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, continues to fulfill its role as a primary supplier for military and veteran healthcare systems through the comprehensive DLA Troop Support Medical vehicle. This delivery order for Zepbound, a diabetes medication, exemplifies the company's ongoing provision of brand-name pharmaceuticals and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency and federal healthcare programs. The competitively awarded contract reflects AmerisourceBergen's established capability to meet federal procurement requirements and supply critical pharmaceutical products to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $68.0k | 7/22/25 |